Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 11.6B | 10.9B | 10.1B | 9.4B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.1B | 925.1M | 918.4M | 812.7M |
| Other operating expenses | 0 | 0 | 0 | 0 |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 7.6B | 6.0B | 5.6B | 5.2B |
| Tax provision | 2.1B | 1.5B | 1.5B | 1.2B |
| Net income | 5.5B | 4.6B | 4.4B | 4.3B |
| Basic EPS | — | 41.3 | 39.6 | 39.5 |
| Diluted EPS | — | 41.3 | 39.6 | 39.5 |
| Basic average shares | — | 110.2M | 110.2M | 110.2M |
| Diluted average shares | — | 110.2M | 110.2M | 110.2M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | 0 | 0 | 0 | 0 |
| Preferred stock dividends | — | — | — | — |